Scientists Investigated Tau Protein Levels in Women
Researchers explored why women show higher tau protein levels despite having equal brain plaque levels to men.
Updated on Oct. 6, 2026 in Alzheimer’s
Live Poll
Should medical research prioritize female-specific health factors to address historical gaps in data?
Scientists are investigating why women exhibit higher tau protein levels than men, despite both genders showing similar levels of amyloid brain plaque. The study focuses on hormonal stages, including pregnancy and menopause, to better understand dementia risks.
Why it matters
Understanding the unique biological factors affecting women is critical to reducing Alzheimer's disease rates. Researchers hope to cut these rates in half by addressing gender-specific differences in brain health.
A review of brain imaging literature published since the 1990s revealed that less than 0.5 percent of articles considered female-specific health factors. The Lancet Commission identified 14 modifiable risk factors that could prevent or delay nearly 45 percent of dementia cases.
The players
The Buckley Lab
This Harvard Medical School research entity maintains a $15 million funding portfolio for its investigation into dementia development.
Kaarin Anstey
She is a professor who received $5 million in funding from the Wellcome Leap CARE project to advance dementia research.
The Lancet Commission
This international group of experts identifies and tracks global modifiable risk factors associated with dementia prevalence.
The details
Researchers compare PET brain scans to monitor the presence of amyloid and tau proteins while analyzing variables such as the age of a first period, pregnancy, and menopause. The Buckley Lab currently holds a $15 million funding portfolio dedicated to these dementia research efforts.
Timeline
The 1990s marked the era when brain imaging research began to proliferate.
Dr. Rachel Buckley began her tenure at Harvard in 2015.
The Big Picture
This research follows the standard set by the Lancet Commission's 14 modifiable risk factors by identifying biological sex as a pivotal, under-studied variable in dementia prevention. It bridges the gap between historical brain imaging paradigms and the need for gender-specific neurological science.
This research may eventually lead to personalized screening protocols that account for a woman's reproductive history and hormonal stages. Patients can monitor their own brain health by discussing lifestyle changes related to the 14 modifiable dementia risk factors with their doctors.
The takeaway
Future dementia prevention strategies must incorporate hormonal and reproductive health data to be effective for the female population. Identifying these specific biological markers is a necessary step toward the long-term goal of halving Alzheimer's disease rates among women.
Further reading
Learn more about the latest developments in the field by visiting our Alzheimer’s research section.
Source note: This article includes information reported by News.
Live Poll
Should medical research prioritize female-specific health factors to address historical gaps in data?
